MedPath

SALLY FALK

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Not Applicable
3 (100.0%)

Oxygen Enhanced MRI Measurement in Head and Neck Cancer: Validation and Efficacy of Response.

Not Applicable
Conditions
Head and Neck Cancer
First Posted Date
2018-08-24
Last Posted Date
2018-08-24
Lead Sponsor
Sally Falk
Target Recruit Count
40
Registration Number
NCT03646747

Simultaneous CBCT Acquisition During Arc Radiotherapy

Not Applicable
Conditions
Prostate Cancer
Lung Cancer
First Posted Date
2014-04-28
Last Posted Date
2015-02-09
Lead Sponsor
Sally Falk
Target Recruit Count
75
Registration Number
NCT02123888
Locations
🇬🇧

The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom

Visual Feedback With Optical Sensing - A Feasibility Study

Not Applicable
Completed
Conditions
Lung Cancer
First Posted Date
2014-02-21
Last Posted Date
2018-02-23
Lead Sponsor
Sally Falk
Target Recruit Count
16
Registration Number
NCT02068378
Locations
🇬🇧

The Christie NHS Foundation Trust, Manchester, Greater Manchester, United Kingdom

News

No news found
© Copyright 2025. All Rights Reserved by MedPath